Teligent (NASDAQ:TLGT) has announced it has received approval for its abbreviated new drug application from the US Food and Drug Administration for its FLuocinonide Cream USP, 1.0 percent. As quoted in the press release:  This is Teligent’s fourth approval of 2019, and its thirty-sixth approval from its internally-developed pipeline of topical generic pharmaceutical medicines. Based … Continued
The post Teligent Receives FDA Approval of Fluocinonide Cream USP, 0.1 Percent appeared first on Investing News Network.
Original Article: Teligent Receives FDA Approval of Fluocinonide Cream USP, 0.1 Percent